Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia on Long-term Outcomes After Scoliosis Correction Surgery: Follow-up of a Randomized Trial

NCT06087510 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT06087510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06087510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia on Long-term Outcomes After Scoliosis Correction Surgery: Follow-up of a Randomized Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
January 24, 2024
Completion date
September 30, 2026
Enrollment
312 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic postsurgical pain, dexmedetomidine, esketamine, postoperative analgesia, scoliosis correction